Decoy Therapeutics share price logo

Decoy Therapeutics

NASDAQ: DCOY

$3.06

+0.01

(+0.33%)

as on

Decoy Therapeutics Stock Performance

as on September 2, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.99
    $3.29
    downward going graph

    2.29%

    Downside

    7.52%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Decoy Therapeutics share price movements today

Previous Close
$3.05
Open
$2.99
Volume
335.1K
Market Cap
$2.0M
Day's Low - High
$2.99 - $3.29

Decoy Therapeutics Historical Returns

1 Month Return
-25.55 %
3 Month Return
-64.46 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Decoy Therapeutics Stock Fundamentals & Key Indicators

Check Decoy Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0M

EPS (TTM)

-29.0937

Dividend Yield

0.00%

PE Ratio (TTM)

-0.1

Industry PE ratio

-1.4626335877862595

PEG Ratio

-0.002127005874937879

Return On Equity TTM

-315.23%

Decoy Therapeutics Stock Valuation

Track how Decoy Therapeutics P/E has moved over time to understand its valuation trends.

Decoy Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-3.81x)

December 31, 2024

Industry (-1.46x)

December 31, 2025

Today (-0.30x)

December 31, 2025

Highest (-0.30x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.30x

Decoy Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Decoy Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$2.0MNA-0.10.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Indian Investors' Interest in Decoy Therapeutics Stock

Search interest for Decoy Therapeutics Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

Decoy Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-8
-
-
Operating Income
-1
-1
-1
-1
-1
0
0
-9
-2
-2
EBITDA
-1
-1
0
-1
-1
0
0
-8
-2
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
-1
-1
0
-1
-1
0
0
-8
-2
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
-1
0
-1
-1
0
0
-8
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Decoy Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
0
3
5
-
-
-
-
-
Gross Profit
0
0
3
5
-
-
-
-
-8
Operating Income
-34
-22
-8
-7
-12
-31
-12
-5
-12
EBITDA
-34
-21
-8
-7
-12
-22
-12
-5
-12
Interest Expense
-
-
-
0
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-34
-21
-6
-7
-12
-31
-12
-5
-12
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-34
-21
-6
-7
-12
-31
-12
-5
-12
Net Profit Margin
60.26%
48.61%
100.00%
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Decoy Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
-1
0
-1
-1
0
0
-8
-2
-2
Operating Cash Flow
-1
-1
-1
0
-1
0
-1
-1
-2
-2
Investing Cash Flow
-
-
-
-
-
-
0
0
-
0
Financing Cash Flow
0
0
1
0
0
0
5
6
-
3
Change in Cash
-1
-1
0
0
0
-1
4
5
-2
0

Decoy Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-34
-21
-6
-7
-12
-31
-12
-5
-12
Operating Cash Flow
-27
-23
-11
-10
-10
-17
-12
-4
-4
Investing Cash Flow
24
14
5
0
-
-1
-
-
0
Financing Cash Flow
0
0
3
17
28
1
6
1
12
Change in Cash
-3
-9
-2
7
18
-17
-6
-3
8

Global Institutional Holdings in Decoy Therapeutics

Funds
Holdings
Vanguard
0.62%
Horizon Kinetics
0%

Insights on Decoy Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 37.1% return, outperforming this stock by 134.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 537.7% return, outperforming this stock by 576.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, DCOY stock has moved down by -25.5%

About Decoy Therapeutics

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company's IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs. It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas.
OrganisationDecoy Therapeutics
Headquarters2450 Holcombe Blvd, Houston, TX, United States, 77021
IndustryBiotechnology
CEOMr. Frederick E. Pierce II
E-voting on sharesClick here to vote

Key Management of Decoy Therapeutics

Name

Title

Mr. Frederick E. Pierce II

CEO & Director

Mr. Mark J. Rosenblum CPA

Executive VP of Finance & CFO

Dr. Barbara Hibner Ph.D.

Chief Scientific Officer

Mr. Peter K. Marschel M.B.A., M.S.

Chief Business Officer

FAQs

What is Decoy Therapeutics share price today?

Decoy Therapeutics share price today is $3.06 as on at the close of the market. Decoy Therapeutics share today touched a day high of $3.29 and a low of $2.99.

What is the 52 week high and 52 week low for Decoy Therapeutics share?

Decoy Therapeutics share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Decoy Therapeutics stock price today i.e. is closed at $3.06,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Decoy Therapeutics's market capitalisation today?

Decoy Therapeutics market capitalisation is $0.00T as on .

How to invest in Decoy Therapeutics Stock (DCOY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Decoy Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Decoy Therapeutics Shares that will get you 0.4902 shares as per Decoy Therapeutics share price of $3.06 per share as on September 2, 2026 at 8:46 am IST.

What is the minimum amount required to buy Decoy Therapeutics Stock (DCOY) from India?

Indian investors can start investing in Decoy Therapeutics (DCOY) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Decoy Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Decoy Therapeutics share’s latest price of $3.06 as on September 2, 2026 at 8:46 am IST, you will get 3.2680 shares of Decoy Therapeutics. Learn more about fractional shares .